Hey Sugar, Fight Cancer by Eliminating Sweets
We all know sugar isn’t “good” for us, but how many of us truly examine the harm it can do. Sugar interferes with our healthy and balanced physiology. Cancel cells thrive on sugar, making it even more problematic. Need proof? When a patient goes in for a PET scan to see if cancer is spreading, they are given dextrose, a form of sugar. Since cancer cells have more receptor sites for sugar than for anything else, the radioactive dye is easier seen on larger cells. It is also makes growth easier to detect.
All of our healthy body cells need oxygen to survive. Cancer cells, however, get energy through fermentation. Simply put, sugar fuels the survival of cancer cells. Continued consumption makes them thrive.
According to researchers at the National Institutes of Health, “High blood sugar and insulin levels also lead to elevated levels of insulin-like growth factor-1 (IGF-1). Milk cows injected with hormones, elevated IGF-1 plays a major role in the progression of many childhood cancers and in the growth of tumors in breast cancer, small cell lung cancer, melanoma, and cancers of the pancreas and prostate. Whether it’s the insulin, the body fat, the inflammation, or the hormones, many studies support the flat-out fact that sugar equals cancer.”
The Journal of the National Cancer Institute in 2004 showed that women who ate the highest glycemic (or sugary) foods were three times more likely to develop colon cancer.
Alternative or Artificial Sweeteners?
Stevia, a natural herb stevia is the recommended alternative sweetener. Xylitol® is also an acceptable alternate. These both work great in baking and will help satisfy cravings for sweets without potentially causing cancer.
Maple syrup and honey are also natural but they will still cause a spike in blood sugar. Only eat in raw, organic forms if you choose these alternatives to sugar. Regular exercise will be required to burn off the extra calories of these natural beauties.
Anything packaged in pink, blue, and yellow packets are made in a lab and should be taken out of consideration. Saccharine, Nutrasweet®, and Splenda® are concentrated chemicals and have no business being in the bloodstream of anyone wanting to stay cancer free.
Sugar is found everyone and is probably impossible to avoid. According to published reports, “the top source of sugar for the vast majority of North Americans is soft drinks. Other sources include processed meats, pizza, sauces, breads, soups, crackers, fruit drinks, canned foods, yogurt, ketchup, and mayonnaise.”
As health conscious consumers, we can do our best to minimize our exposure. Start by making it a habit to read the ingredients of the foods we eat. Would you be alarmed to know that sugar is consumed at an average of 120 pounds per person each year? That looks like an area with ample opportunity for improvement on our own behalves.
This Just In… Other Cancer News
Incrementally, progress in our fight against cancer is being made. Perhaps, not as quickly as we’d like. Perhaps not in time to save the lives of people we love but increased awareness, healthier lifestyles, research and technology is moving us forward. We are becoming smarter about cancer and advancement, if not cures, are on the horizon.
Exciting news regarding new anticancer drugs have recently been announced. Johnson & Johnson has reportedly purchased the company that produces Imbruvica, a pill used to treat chronic lymphocytic leukemia and other rarer blood cancers. With the backing of Johnson & Johnson, it is speculated that other anticancer drugs may be on the horizon.
The Food and Drug Administration has approved the first immune therapy drug for lung cancer. Opdivo, has shown good results against melanoma. Additional testing has shown it can work against squamous non-small cell lung cancer, one of several types of lung cancer. The FDA granted approval after confirming claims that, “Opdivo, known generically as nivolumab, is a so-called monoclonal antibody. These are lab engineered immune system proteins that help the body attack and kill tumors.”
In the United States, with an estimated 224,210 new diagnoses and 159,260 deaths in 2014, lung cancer is the leading cause of cancer death. Any advancement in the battle against this disease is exciting.
It is reported that in tests, lung cancer patients who got Opdivo lived an average of three months longer than those who got the standard chemotherapy drug docetaxel. It may not sound like much but some patients lived much longer. When stage 4 lung cancer is almost a certain death sentence, three more months is a lifetime.
Researchers at MIT have developed a new Nanodevice that defeats drug resistance.
The device, which consists of gold nanoparticles embedded in a hydrogel that can be injected or implanted at a tumor site, can also be used more broadly to disrupt any gene involved in cancer.
“You can target any genetic marker and deliver a drug, including those that don’t necessarily involve drug-resistance pathways. It’s a universal platform for dual therapy,” says Natalie Artzi, a research scientist at MIT’s Institute for Medical Engineering and Science (IMES), an assistant professor at Harvard Medical School, and senior author of a paper describing the device in the Proceedings of the National Academy of Sciences the week of March 2.